Pediatric Hematology-Oncology Cellular Therapy & Bone Marrow Transplant Clinical Investigator or Physician Scientist

The Division of Pediatric Hematology-Oncology at Guerin Children’s and Cedars-Sinai Cancer is seeking a full time Pediatric Hematology-Oncology Physician Scientist to expand a new Cell Therapy & Bone Marrow Transplant (BMT) for children and adolescents. Cedars-Sinai Cancer boasts an established FACT-approved cell therapy and BMT program for adults, recognized for its strong basic, translational, and clinical research initiatives. We are seeking mid- to late-career professionals with proven leadership in program development, board certification in pediatric hematology-oncology, and eligibility for California medical licensure. Candidates should qualify for an academic appointment at the Associate Professor or Professor level at Cedars-Sinai Health Sciences University.

This is a unique opportunity to join a robust multidisciplinary pediatric hematology-oncology team within a nationally recognized clinical and research institution, ranked # 1 in California and a US News and World Report Honor Roll Hospital in 2025.  The successful candidate will benefit from a highly collaborative ecosystem that includes the Cedars-Sinai Regenerative Medicine Institute, with advanced immunology platforms and state of the art GMP facilities that support cellular therapy development from bench to bedside.

 

Cedars-Sinai Guerin Children’s is a rapidly growing tertiary and quaternary pediatric center, made possible by a $100 million gift from the Shapell Guerin Family Foundation. With a 26-bed mixed subspecialty unit, 12-bed PICU, and 45-bed NICU, Guerin Children’s offers comprehensive care from birth through adolescence. The pediatric enterprise includes over 125 clinical and research faculty across all subspecialties. Collaborative opportunities abound with leading programs in Developmental Biology and innovative cell therapy initiatives in Neurology and Gastroenterology, helping to shape the future of precision medicine and pediatric care.

Discovery is a core value to Cedars-Sinai’s mission. The institution’s laboratories and clinics generate ideas, therapies, devices and systems that contribute to biomedical progress around the world. More than 2,000 current research projects explore the full breadth of biomedical research, some of which include investigating genetic therapies for pediatric conditions, organ development and regeneration, connections among diabetes, chronic pancreatitis and pancreatic cancer, exploiting the potential of stem cells, leveraging nanotechnology, parsing big data, and assessing the developmental origins of disease. During the last five years, Cedars-Sinai has doubled its federal awards, with our FY24 federal awards totaling over $150 million and $300 million+ in research expenses.

 

FY24 Cedars-Sinai Research Metrics:

· #10 in Total NIH Funding among independent hospitals in the U.S.

· 612 grants

· 638 clinical trials

· $300+ Million in research expenses

· 540,000 square feet of wet and dry lab space

· 2,100+ Research projects

· 2,400+ Peer-reviewed faculty publications

· 21 research cores, including our Biomanufacturing Center/iPSC core, flow cytometry, and molecular therapeutics

 

 

Interested candidates may apply by submitting their CV, cover letter, and names of three references to Leo Mascarenhas, MD, MS.

We offer competitive total compensation that includes pay, benefits, and other incentive programs for our employees.  The pay range shown takes into account the wide range of factors that are considered in making compensation decisions including knowledge/skills; relevant experience and training; education/certifications/licensure; and other business and organizational factors.  This pay range includes any incentive payments that may be applicable to this role. We also offer a comprehensive faculty benefits package. Resources to enable significant program building will also be available.

Pay Range: $213,326 – $491,437 total cash compensation 

Qualifications

• Medical Degree from an accredited university
• Board certification in pediatric hematology-oncology
• California medical licensure
• Proven leadership in program development
• Associate Professor or Professor level